WRCDF yields 666666.67% · PFE yields 6.13%● Live data
📍 WRCDF pulled ahead of the other in Year 1
Combined, WRCDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WRCDF + PFE for your $10,000?
Wirecard AG, a technology company, provides outsourcing and white label solutions for electronic payments worldwide. The company operates in three segments: Payment Processing & Risk Management, Acquiring & Issuing, and Call Center & Communication Services. The Payment Processing & Risk Management segment offers products and service for the acceptance or transactions, and the processing of electronic payments and associated processes. The Acquiring & Issuing segment provides settlement services for credit card sales for online and terminal payments, as well as current accounts with prepaid cards and Girocard/Maestro debit cards; processes payment transactions in various currencies; and issues prepaid and debit cards to private and business customers. The Call Center & Communication Services segment offers value added services, aftersales services to customers, and mailing services. The company also provides payment processing solutions that include Wirecard Payment Page, a payment page; credit card processing; direct debit; online banking payment; alternative payment; international payment processing; tokenization; point of sale terminals; and Wirecard Checkout Portal, a payment portal. In addition, it offers mobile payment solutions; risk management solutions, such as fraud prevention, credit worthiness checks, and individual solutions; integration and testing solutions, including enterprise integration, transaction testing, payment hub, customer self-select PIN, and secure mailer solutions; and communication services. The company serves the consumer goods, digital goods, and travel and mobility sectors. Wirecard has strategic partnerships with Poynt, CreditPilot PLC, SunExpress, and Emonvia. Wirecard AG was founded in 1999 and is headquartered in Aschheim, Germany.
Full WRCDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.